Biological hazards

UT Health San Antonio researchers study antibodies against coronavirus

Retrieved on: 
Tuesday, May 5, 2020

SAN ANTONIO, May 5, 2020 /PRNewswire-PRWeb/ --As laboratories across the country rush to find answers for the novel coronavirus, The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is bringing a unique combination of expertise to bear on the crisis.

Key Points: 
  • SAN ANTONIO, May 5, 2020 /PRNewswire-PRWeb/ --As laboratories across the country rush to find answers for the novel coronavirus, The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is bringing a unique combination of expertise to bear on the crisis.
  • UT Health San Antonio has repurposed strategic teams in its research enterprise to focus on the problem, he said.
  • UT Health San Antonio researchers are working with colleagues at the Texas Biomedical Research Institute, where biosafety level 3 and 4 labs enable scientists to work with live virus.
  • The University of Texas Health Science Center at San Antonio , also referred to as UT Health San Antonio, is one of the country's leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education.

Huge Increase in Medical Waste Amid COVID-19 Pandemic - Its Safe Disposal is Becoming a Bigger Concern

Retrieved on: 
Tuesday, May 5, 2020

DUBLIN, May 5, 2020 /PRNewswire/ -- ResearchAndMarkets.com published a new article on the healthcare industry, "Medical Waste Sector Sees Rising Demand During COVID-19 Pandemic"

Key Points: 
  • DUBLIN, May 5, 2020 /PRNewswire/ -- ResearchAndMarkets.com published a new article on the healthcare industry, "Medical Waste Sector Sees Rising Demand During COVID-19 Pandemic"
    The COVID-19 pandemic has created a huge increase in medical waste in particular plastic waste and its safe disposal is becoming a bigger concern.
  • The US has seen a surge in medical waste from discarded personal protective equipment as well as an increase in other items that must be treated as medical waste after coming into contact with a COVID-19 patient.
  • The Center for Disease Control has advised that medical waste from COVID-19 can be treated the same as other medical waste.
  • Although there has been a huge increase in COVID-19 related medical waste, the decrease in waste due to the cancellation of non-critical and elective surgeries have prevented the medical waste sector from becoming overwhelmed.

Sharps Compliance to Participate in the Oppenheimer 5th Annual Emerging Growth Conference

Retrieved on: 
Tuesday, May 5, 2020

HOUSTON, May 05, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, Chief Executive Officer has been invited to participate in Oppenheimers 5th Annual Emerging Growth Conference, which will take place virtually on Tuesday, May 12, 2020.

Key Points: 
  • HOUSTON, May 05, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, Chief Executive Officer has been invited to participate in Oppenheimers 5th Annual Emerging Growth Conference, which will take place virtually on Tuesday, May 12, 2020.
  • Mr. Tusa will be available throughout the day for one-on-one and small group meetings via teleconference.
  • Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous.
  • Sharps also provides two simple solutions for safe and easy disposal of unused medications: MedSafe collection receptacles and TakeAway Medication Recovery System Envelopes.

Medical Waste Sector Sees Rising Demand During COVID-19 Pandemic - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 5, 2020

ResearchAndMarkets.com published a new article on the healthcare industry, "Medical Waste Sector Sees Rising Demand During COVID-19 Pandemic"

Key Points: 
  • ResearchAndMarkets.com published a new article on the healthcare industry, "Medical Waste Sector Sees Rising Demand During COVID-19 Pandemic"
    The COVID-19 pandemic has created a huge increase in medical waste in particular plastic waste and its safe disposal is becoming a bigger concern.
  • The Center for Disease Control has advised that medical waste from COVID-19 can be treated the same as other medical waste.
  • Although there has been a huge increase in COVID-19 related medical waste, the decrease in waste due to the cancellation of non-critical and elective surgeries have prevented the medical waste sector from becoming overwhelmed.
  • Companies like Stericycle, Technopath Clinical Diagnostics, Biomedical Waste Solutions and MedPro Disposal are seeing increased demand for their medical waste treatment and disposal services.

Vaporesso is taking actions to fight against the epidemic of COVID-19

Retrieved on: 
Tuesday, April 28, 2020

Facing the COVID-19 pandemic around the world, Vaporesso has purchased over 100,000 masks and sent them to distributors, V shops, online influencers, and official website users for free.

Key Points: 
  • Facing the COVID-19 pandemic around the world, Vaporesso has purchased over 100,000 masks and sent them to distributors, V shops, online influencers, and official website users for free.
  • Currently, Vaporesso is concerned with the emergence of epidemics overseas and has formulated a series of preventive measures for partners and customers.
  • Secondly, Vaporesso provides customers with information package services and uses several platforms like their website and social media accountsto distribute manuals andlive stream to raise awareness about epidemic prevention.
  • Allied with other online platforms, Vaporesso has more than 10,000 OSMALL kits prepared for its customers to help themchill during the staying.

Sharps Compliance Receives Paycheck Protection Program Loan

Retrieved on: 
Tuesday, April 21, 2020

HOUSTON, April 21, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance, Inc., a subsidiary of Sharps Compliance Corp. (NASDAQ: SMED) (Sharps or the Company), today announced that it has received loan proceeds of $2.2 million under the Paycheck Protection Program (PPP) under a promissory note from its commercial bank (the PPP Loan).

Key Points: 
  • HOUSTON, April 21, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance, Inc., a subsidiary of Sharps Compliance Corp. (NASDAQ: SMED) (Sharps or the Company), today announced that it has received loan proceeds of $2.2 million under the Paycheck Protection Program (PPP) under a promissory note from its commercial bank (the PPP Loan).
  • The annual interest rate on the PPP Loan is 1% and no payments of principal or interest are due during the six-month period beginning on the date of the PPP Loan.
  • Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous.
  • The information made available in this news release contains certain forward-looking statements which reflect Sharps Compliance Corp.'s current view of future events and financial performance.

Virginia Business Launches Recruiting and Management Program For COVID-19 Contact Tracing

Retrieved on: 
Friday, April 17, 2020

AM launched a comprehensive, 50-state effort to identify and vet qualified health surveillance officers who can be tasked or deployed to support government contact tracing efforts.

Key Points: 
  • AM launched a comprehensive, 50-state effort to identify and vet qualified health surveillance officers who can be tasked or deployed to support government contact tracing efforts.
  • Contact tracing is one of the interventions that has been used to effectively control recent pandemics, e.g.
  • CDC Director Dr. Robert Redfield recently told NPR the plan to reopen the U.S. will rely on "very aggressive" contact tracing.
  • According to April 2020 John Hopkins "COVID-19 Case Findings," the U.S. public health workforce is underfunded by a factor of billions to complete contact tracing work.

Sharps Compliance Announces Third Quarter Fiscal 2020 Conference Call and Webcast

Retrieved on: 
Tuesday, April 14, 2020

HOUSTON, April 14, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that it will release its third quarter 2020 results for the period ended March 31, 2019, before the opening of the financial markets on Tuesday, April 28, 2020.

Key Points: 
  • HOUSTON, April 14, 2020 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that it will release its third quarter 2020 results for the period ended March 31, 2019, before the opening of the financial markets on Tuesday, April 28, 2020.
  • A conference call and webcast will follow at 11:00 a.m.
  • The Sharps conference call can be accessed by domestic callers by dialing (877) 407-0782. International callers may access the call by dialing (201) 689-8567.
  • Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services including medical, pharmaceutical and hazardous.

BGI Unveils Huo-Yan Air Lab Rapid Deployment Inflatable Biosafety Laboratory for Fast and Effective COVID-19 In-country Testing

Retrieved on: 
Wednesday, April 8, 2020

In order to address this unprecedented challenge, BGI, in collaboration with the company Etopia, have jointly designed a mobile, inflatable P2 level biosafety laboratory: the "Huo-Yan Air Lab."

Key Points: 
  • In order to address this unprecedented challenge, BGI, in collaboration with the company Etopia, have jointly designed a mobile, inflatable P2 level biosafety laboratory: the "Huo-Yan Air Lab."
  • Huo-Yan is based on BGI's previous experience constructing aP3 level biosafety laboratory using an inflatable structure during the Ebola outbreak in 2014 in West Africa.
  • "The Huo-Yan Air Lab fully meets the demands of global biosafety requirements and industry specifications," notes YIN Ye, CEO of BGI Genomics.
  • At the unveiling ceremony it was announced that the laboratory aims to obtain third-party certification for testing in the near future.

Curiox Biosystems and STEMCELL Technologies Announce Method to Safely Prepare COVID-19 Blood Samples for Vaccine Research

Retrieved on: 
Monday, April 6, 2020

The package will consist of an updated Laminar Wash HT1000 system, Buffer Exchanger, and STEMCELL Technologies' EasySep RBC Depletion Reagent.

Key Points: 
  • The package will consist of an updated Laminar Wash HT1000 system, Buffer Exchanger, and STEMCELL Technologies' EasySep RBC Depletion Reagent.
  • The new HT1000 configuration allows containment of blood samples within a biosafety cabinet, ensuring the protection of laboratory staff and other samples.
  • Enabling safe and efficient handling of virus-positive blood samples ultimately helps patients by accelerating treatment and vaccine research.
  • Curiox Biosystems is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore.